International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 3 , Pages 574-580 , 1 July 2002

The role of p53 in radiation therapy outcomes for favorable-to-intermediate-risk prostate cancer

Presented at the 43rd Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Francisco, CA, November, 2001.

  • Mark A Ritter, M.D., Ph.D.

      Affiliations

    • Corresponding Author InformationReprint requests and correspondence to: Mark A. Ritter, M.D., Ph.D., Department of Human Oncology, K4/B100, 600 Highland Ave., Madison, WI 53792 USA. Tel: (608) 263-8509; Fax: (608) 263-9167
    • Department of Human Oncology, University of Wisconsin, Madison, WI USA
  • ,
  • Kennedy W Gilchrist, M.D.

      Affiliations

    • Department of Pathology, University of Wisconsin, Madison, WI USA
  • ,
  • Marta Voytovich, M.D.

      Affiliations

    • Department of Pathology, University of Wisconsin, Madison, WI USA
  • ,
  • Richard J Chappell, Ph.D.

      Affiliations

    • Department of Biostatistics, University of Wisconsin, Madison, WI, USA
  • ,
  • Bret M Verhoven

      Affiliations

    • Department of Human Oncology, University of Wisconsin, Madison, WI USA

Received 11 December 2001 ,Accepted 28 January 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0360-3016(02)02781-5

International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 3 , Pages 574-580 , 1 July 2002